Final overall survival analysis of MONARCH 1

Redefining tamoxifen for breast cancer

Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours

Neratinib in HER2 or HER3 mutant solid tumours

Surgical and social perspectives on nipple sparing mastectomy

Mechanisms of resistance in triple negative breast cancer

Cyclin dependent kinases to treat metastatic breast cancer

De-escalating and escalating surgery in the management of early breast cancer

Personalising breast cancer therapies

CDK 4/6 inhibitors for metastatic breast cancer

Next steps for treating breast cancer

Conference goals and cancer care in Brazil